Novo Nordisk shares dive 9% after heart medicine fails trial
--------------------------------------------------------------------
Source: CNBC
Published: 2026-07-31 21:39 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Law & Courts, Drugs, Crime & Justice
--------------------------------------------------------------------
Snippet:
Shares of Novo Nordisk nosedived as much as 10% after the drugmaker said a late-stage heart drug trial failed to reduce major cardiovascular events compared to placebo.
--------------------------------------------------------------------